跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21 条关于
“OV4071”
全部
21
临床试验
9
药物
5
机构
0
资讯
7
9个月前
Ovid Therapeutics Reports First-in-Human Safety Data for Novel KCC2 Direct Activator OV350
11个月前
Ovid Therapeutics Secures $175M PIPE Financing to Advance CNS Drug Pipeline Through 2028
去年
Ovid Therapeutics Sells Ganaxolone Royalty Rights to Immedica Pharma for $7 Million
2个月前
Ovid Therapeutics Reshapes Executive Leadership to Drive Next Phase of CNS Pipeline Development
10个月前
Ovid Therapeutics Advances OV329 to Phase 2 Following Positive Safety Results in Drug-Resistant Epilepsy Program
去年
Ovid Therapeutics Advances Novel Neurological Drug Pipeline with Key Clinical Milestones Expected in 2025-2026
11个月前
Ovid Therapeutics' OV329 Shows 53% GABA Inhibition in Phase 1 Trial for Drug-Resistant Epilepsy